Osteoarthritis and Bone Disorders News

A belt device that mechanically stimulates bones through vibration slowed the decline in bone strength among adults with osteopenia, according to top-line results announced in an industry press release.

PHILADELPHIA — Denosumab successfully induces structural modifications patients with active erosive hand osteoarthritis, according to data presented at ACR Convergence 2022.

PHILADELPHIA — A daily glucocorticoid dose higher than 2.5 mg may lead to irreversible bone mineral density loss regardless of intervention with osteoporosis medications, according to data presented at ACR Convergence 2022.

Patients with knee osteoarthritis who are overweight or obese saw reduced knee pain following 18 months of diet and exercise instruction delivered in a community space, according to data presented at ACR Convergence 2022.

PHILADELPHIA — Nearly half of patients with spine disease reported no back pain at CRMO onset, and one-third were asymptomatic despite active lesions on whole body MRI at diagnosis, according to data presented at ACR Convergence 2022.

Models based on electronic health records may estimate the risk for chronic opioid use in patients with osteoarthritis, according to data published in Arthritis Care & Research.

SAN DIEGO — Matching the correct therapy sequence to the right patient is critical when caring for patients with osteoporosis, according to a speaker at the Congress of Clinical Rheumatology West.

SAN DIEGO — Older individuals experience reduced immune activity and increased inflammation that often resemble rheumatic and autoimmune diseases, according to data presented at the Congress of Clinical Rheumatology West.

SAN DIEGO — Patients with low bone density may have osteoporosis despite registering a bone mineral density score higher than –2.5, according to a speaker at the Congress of Clinical Rheumatology West

SAN DIEGO — The key to developing effective therapies for the management of osteoarthritis may lie in appreciating neuroplasticity in patients with the disease, according to a speaker at the Congress of Clinical Rheumatology West.